0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RDC (Radionuclide Drug Conjugate) Services Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-33G18300
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global RDC Radionuclide Drug Conjugate Services Market Research Report 2024
BUY CHAPTERS

Global RDC (Radionuclide Drug Conjugate) Services Market Research Report 2024

Code: QYRE-Auto-33G18300
Report
October 2024
Pages:66
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

RDC (Radionuclide Drug Conjugate) Services Market

RDC (Radionuclide Drug Conjugate) services refer to professional services provided for the development, production and application of radionuclide drug conjugates. These conjugates usually combine radioisotopes with drugs (such as monoclonal antibodies, peptides or small molecules) to target specific cells or tissues for treatment, especially in cancer treatment. The main contents of RDC services include drug development, radionuclide labeling and screening, preclinical research (evaluation of drug conjugates), etc.
The global RDC (Radionuclide Drug Conjugate) Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for RDC (Radionuclide Drug Conjugate) Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RDC (Radionuclide Drug Conjugate) Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RDC (Radionuclide Drug Conjugate) Services in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RDC (Radionuclide Drug Conjugate) Services include Rdcthera, Abzena, WuXi XDC, CD Formulation, CPC Scientific Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RDC (Radionuclide Drug Conjugate) Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RDC (Radionuclide Drug Conjugate) Services.
The RDC (Radionuclide Drug Conjugate) Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RDC (Radionuclide Drug Conjugate) Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RDC (Radionuclide Drug Conjugate) Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of RDC (Radionuclide Drug Conjugate) Services Market Report

Report Metric Details
Report Name RDC (Radionuclide Drug Conjugate) Services Market
Segment by Type
Segment by Application
  • Pharmaceutical Companies
  • Medical Device Companies
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Rdcthera, Abzena, WuXi XDC, CD Formulation, CPC Scientific Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of RDC (Radionuclide Drug Conjugate) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RDC (Radionuclide Drug Conjugate) Services Market report?

Ans: The main players in the RDC (Radionuclide Drug Conjugate) Services Market are Rdcthera, Abzena, WuXi XDC, CD Formulation, CPC Scientific Inc

What are the Application segmentation covered in the RDC (Radionuclide Drug Conjugate) Services Market report?

Ans: The Applications covered in the RDC (Radionuclide Drug Conjugate) Services Market report are Pharmaceutical Companies, Medical Device Companies, Other

What are the Type segmentation covered in the RDC (Radionuclide Drug Conjugate) Services Market report?

Ans: The Types covered in the RDC (Radionuclide Drug Conjugate) Services Market report are Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)

Recommended Reports

Radiation Therapy Devices

Radiopharmaceuticals Markets

Conjugates and Adjacent

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody Radionuclide Conjugates (ARC)
1.2.3 Peptide Radionuclide Conjugates (PRC)
1.2.4 Small Molecular Radionuclide Conjugates (SMRC)
1.3 Market by Application
1.3.1 Global RDC (Radionuclide Drug Conjugate) Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Perspective (2019-2030)
2.2 Global RDC (Radionuclide Drug Conjugate) Services Growth Trends by Region
2.2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Region (2019-2024)
2.2.3 RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Region (2025-2030)
2.3 RDC (Radionuclide Drug Conjugate) Services Market Dynamics
2.3.1 RDC (Radionuclide Drug Conjugate) Services Industry Trends
2.3.2 RDC (Radionuclide Drug Conjugate) Services Market Drivers
2.3.3 RDC (Radionuclide Drug Conjugate) Services Market Challenges
2.3.4 RDC (Radionuclide Drug Conjugate) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RDC (Radionuclide Drug Conjugate) Services Players by Revenue
3.1.1 Global Top RDC (Radionuclide Drug Conjugate) Services Players by Revenue (2019-2024)
3.1.2 Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Players (2019-2024)
3.2 Global RDC (Radionuclide Drug Conjugate) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RDC (Radionuclide Drug Conjugate) Services Revenue
3.4 Global RDC (Radionuclide Drug Conjugate) Services Market Concentration Ratio
3.4.1 Global RDC (Radionuclide Drug Conjugate) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RDC (Radionuclide Drug Conjugate) Services Revenue in 2023
3.5 Global Key Players of RDC (Radionuclide Drug Conjugate) Services Head office and Area Served
3.6 Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Product and Application
3.7 Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RDC (Radionuclide Drug Conjugate) Services Breakdown Data by Type
4.1 Global RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Type (2019-2024)
4.2 Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Type (2025-2030)
5 RDC (Radionuclide Drug Conjugate) Services Breakdown Data by Application
5.1 Global RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Application (2019-2024)
5.2 Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RDC (Radionuclide Drug Conjugate) Services Market Size (2019-2030)
6.2 North America RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024)
6.4 North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RDC (Radionuclide Drug Conjugate) Services Market Size (2019-2030)
7.2 Europe RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024)
7.4 Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size (2019-2030)
8.2 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2019-2024)
8.4 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size (2019-2030)
9.2 Latin America RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024)
9.4 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size (2019-2030)
10.2 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024)
10.4 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Rdcthera
11.1.1 Rdcthera Company Details
11.1.2 Rdcthera Business Overview
11.1.3 Rdcthera RDC (Radionuclide Drug Conjugate) Services Introduction
11.1.4 Rdcthera Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
11.1.5 Rdcthera Recent Development
11.2 Abzena
11.2.1 Abzena Company Details
11.2.2 Abzena Business Overview
11.2.3 Abzena RDC (Radionuclide Drug Conjugate) Services Introduction
11.2.4 Abzena Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
11.2.5 Abzena Recent Development
11.3 WuXi XDC
11.3.1 WuXi XDC Company Details
11.3.2 WuXi XDC Business Overview
11.3.3 WuXi XDC RDC (Radionuclide Drug Conjugate) Services Introduction
11.3.4 WuXi XDC Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
11.3.5 WuXi XDC Recent Development
11.4 CD Formulation
11.4.1 CD Formulation Company Details
11.4.2 CD Formulation Business Overview
11.4.3 CD Formulation RDC (Radionuclide Drug Conjugate) Services Introduction
11.4.4 CD Formulation Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
11.4.5 CD Formulation Recent Development
11.5 CPC Scientific Inc
11.5.1 CPC Scientific Inc Company Details
11.5.2 CPC Scientific Inc Business Overview
11.5.3 CPC Scientific Inc RDC (Radionuclide Drug Conjugate) Services Introduction
11.5.4 CPC Scientific Inc Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
11.5.5 CPC Scientific Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Antibody Radionuclide Conjugates (ARC)
 Table 3. Key Players of Peptide Radionuclide Conjugates (PRC)
 Table 4. Key Players of Small Molecular Radionuclide Conjugates (SMRC)
 Table 5. Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2019-2024)
 Table 9. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2025-2030)
 Table 11. RDC (Radionuclide Drug Conjugate) Services Market Trends
 Table 12. RDC (Radionuclide Drug Conjugate) Services Market Drivers
 Table 13. RDC (Radionuclide Drug Conjugate) Services Market Challenges
 Table 14. RDC (Radionuclide Drug Conjugate) Services Market Restraints
 Table 15. Global RDC (Radionuclide Drug Conjugate) Services Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Players (2019-2024)
 Table 17. Global Top RDC (Radionuclide Drug Conjugate) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RDC (Radionuclide Drug Conjugate) Services as of 2023)
 Table 18. Ranking of Global Top RDC (Radionuclide Drug Conjugate) Services Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by RDC (Radionuclide Drug Conjugate) Services Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Headquarters and Area Served
 Table 21. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Product and Application
 Table 22. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Type (2019-2024)
 Table 26. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Type (2025-2030)
 Table 28. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Application (2019-2024)
 Table 30. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Application (2025-2030)
 Table 32. North America RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Rdcthera Company Details
 Table 48. Rdcthera Business Overview
 Table 49. Rdcthera RDC (Radionuclide Drug Conjugate) Services Product
 Table 50. Rdcthera Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
 Table 51. Rdcthera Recent Development
 Table 52. Abzena Company Details
 Table 53. Abzena Business Overview
 Table 54. Abzena RDC (Radionuclide Drug Conjugate) Services Product
 Table 55. Abzena Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
 Table 56. Abzena Recent Development
 Table 57. WuXi XDC Company Details
 Table 58. WuXi XDC Business Overview
 Table 59. WuXi XDC RDC (Radionuclide Drug Conjugate) Services Product
 Table 60. WuXi XDC Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
 Table 61. WuXi XDC Recent Development
 Table 62. CD Formulation Company Details
 Table 63. CD Formulation Business Overview
 Table 64. CD Formulation RDC (Radionuclide Drug Conjugate) Services Product
 Table 65. CD Formulation Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
 Table 66. CD Formulation Recent Development
 Table 67. CPC Scientific Inc Company Details
 Table 68. CPC Scientific Inc Business Overview
 Table 69. CPC Scientific Inc RDC (Radionuclide Drug Conjugate) Services Product
 Table 70. CPC Scientific Inc Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
 Table 71. CPC Scientific Inc Recent Development
 Table 72. Research Programs/Design for This Report
 Table 73. Key Data Information from Secondary Sources
 Table 74. Key Data Information from Primary Sources
 Table 75. Authors List of This Report


List of Figures
 Figure 1. RDC (Radionuclide Drug Conjugate) Services Picture
 Figure 2. Global RDC (Radionuclide Drug Conjugate) Services Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Type: 2023 VS 2030
 Figure 4. Antibody Radionuclide Conjugates (ARC) Features
 Figure 5. Peptide Radionuclide Conjugates (PRC) Features
 Figure 6. Small Molecular Radionuclide Conjugates (SMRC) Features
 Figure 7. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Application: 2023 VS 2030
 Figure 9. Pharmaceutical Companies Case Studies
 Figure 10. Medical Device Companies Case Studies
 Figure 11. Other Case Studies
 Figure 12. RDC (Radionuclide Drug Conjugate) Services Report Years Considered
 Figure 13. Global RDC (Radionuclide Drug Conjugate) Services Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global RDC (Radionuclide Drug Conjugate) Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region: 2023 VS 2030
 Figure 16. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Players in 2023
 Figure 17. Global Top RDC (Radionuclide Drug Conjugate) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RDC (Radionuclide Drug Conjugate) Services as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by RDC (Radionuclide Drug Conjugate) Services Revenue in 2023
 Figure 19. North America RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2019-2030)
 Figure 21. United States RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2019-2030)
 Figure 25. Germany RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2019-2030)
 Figure 33. China RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2019-2030)
 Figure 41. Mexico RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2019-2030)
 Figure 45. Turkey RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Rdcthera Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
 Figure 49. Abzena Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
 Figure 50. WuXi XDC Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
 Figure 51. CD Formulation Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
 Figure 52. CPC Scientific Inc Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension